6501 related articles for article (PubMed ID: 2999496)
1. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human bone marrow progenitors (CFU-C) and human clonogenic tumor cells implanted into mice.
Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
J Natl Cancer Inst; 1985 Dec; 75(6):1059-66. PubMed ID: 2999496
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth and drug sensitivity of tumor colony-forming units from human tumor xenografts.
Taetle R; Koessler AK; Howel SB
Cancer Res; 1981 May; 41(5):1856-60. PubMed ID: 7214353
[TBL] [Abstract][Full Text] [Related]
3. Effects of human bone marrow stroma on the growth of human tumor cells.
Strobel ES; Strobel HG; Bross KJ; Winterhalter B; Fiebig HH; Schildge JU; Löhr GW
Cancer Res; 1989 Feb; 49(4):1001-7. PubMed ID: 2912545
[TBL] [Abstract][Full Text] [Related]
4. Goralatide (AcSDKP) selectively protects murine hematopoietic progenitors and stem cells against hyperthermic damage.
Wierenga PK; Konings AW
Exp Hematol; 1996 Feb; 24(2):246-52. PubMed ID: 8641348
[TBL] [Abstract][Full Text] [Related]
5. Response of human squamous cell carcinoma xenografts of different sizes to irradiation: relationship of clonogenic cells, cellular radiation sensitivity in vivo, and tumor rescuing units.
Baumann M; Dubois W; Suit HD
Radiat Res; 1990 Sep; 123(3):325-30. PubMed ID: 2145606
[TBL] [Abstract][Full Text] [Related]
6. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
[TBL] [Abstract][Full Text] [Related]
7. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
8. Treatment of human clonogenic tumor cells and bone marrow progenitor cells with bleomycin and peplomycin under 40.5 degrees C hyperthermia in vitro.
Neumann HA; Herrmann DB; Fiebig HH; Engelhardt R
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):99-104. PubMed ID: 2465897
[TBL] [Abstract][Full Text] [Related]
9. Cytostatic drug effects on human clonogenic tumor cells and human bone marrow progenitor cells (CFU-C) in vitro.
Neumann HA; Fiebig HH; Engelhardt R; Löhr GW
Res Exp Med (Berl); 1985; 185(1):51-6. PubMed ID: 3969521
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytostatic drugs and 40.5 degrees C hyperthermia on human clonogenic tumor cells.
Neumann HA; Fiebig HH; Löhr GW; Engelhardt R
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):515-23. PubMed ID: 2988968
[TBL] [Abstract][Full Text] [Related]
11. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
[TBL] [Abstract][Full Text] [Related]
12. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
[TBL] [Abstract][Full Text] [Related]
13. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells.
Gidáli J; Fehér I; Kovács P
Stem Cells; 1994 Sep; 12(5):533-8. PubMed ID: 7804126
[TBL] [Abstract][Full Text] [Related]
14. Thermal response and hyperthermic radiosensitization of scid mouse bone marrow CFU-C.
O'Hara MD; Pollard MD; Wheatley G; Regine WF; Mohiuddin M; Leeper DB
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):905-10. PubMed ID: 7860404
[TBL] [Abstract][Full Text] [Related]
15. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of hyperthermia alone or in combination with cisplatin and melphalan in primary cultures of human malignant melanoma.
Zaffaroni N; Villa R; Daidone MG; Vaglini M; Santinami M; Silvestrini R
Int J Cell Cloning; 1989 Nov; 7(6):385-94. PubMed ID: 2809274
[TBL] [Abstract][Full Text] [Related]
17. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
18. The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.
Slanicka Krieger M; Nissen C; Manz CY; Toksoz D; Lyman SD; Wodnar-Filipowicz A
Exp Hematol; 1998 May; 26(5):365-73. PubMed ID: 9590652
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
[TBL] [Abstract][Full Text] [Related]
20. In vitro test-system for chemo- and thermosensitivity: an analysis of survival fractions and cell-cycle distributions in human Ewing's sarcomas as a modelfor tumors in pediatric oncology.
Debes A; Rommel F; Breise M; Willers R; Göbel U; Wessalowski R
Klin Padiatr; 2002; 214(4):223-9. PubMed ID: 12165906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
